IE43380B1 - Process for preparing viruses - Google Patents
Process for preparing virusesInfo
- Publication number
- IE43380B1 IE43380B1 IE123476A IE123476A IE43380B1 IE 43380 B1 IE43380 B1 IE 43380B1 IE 123476 A IE123476 A IE 123476A IE 123476 A IE123476 A IE 123476A IE 43380 B1 IE43380 B1 IE 43380B1
- Authority
- IE
- Ireland
- Prior art keywords
- virus
- serum
- cells
- medium
- culture medium
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims description 33
- 238000004519 manufacturing process Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims description 24
- 239000001963 growth medium Substances 0.000 claims description 16
- 239000002609 medium Substances 0.000 claims description 16
- 210000002966 serum Anatomy 0.000 claims description 16
- 208000015181 infectious disease Diseases 0.000 claims description 14
- 229960005486 vaccine Drugs 0.000 claims description 10
- 238000010790 dilution Methods 0.000 claims description 9
- 239000012895 dilution Substances 0.000 claims description 9
- 241000710198 Foot-and-mouth disease virus Species 0.000 claims description 8
- 239000004017 serum-free culture medium Substances 0.000 claims description 8
- 238000004113 cell culture Methods 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 241000282887 Suidae Species 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- 229940041514 candida albicans extract Drugs 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 241000701161 unidentified adenovirus Species 0.000 claims description 4
- 239000012138 yeast extract Substances 0.000 claims description 4
- 229930193140 Neomycin Natural products 0.000 claims description 3
- 241000702263 Reovirus sp. Species 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 229960004927 neomycin Drugs 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 241000709661 Enterovirus Species 0.000 claims description 2
- 102000004407 Lactalbumin Human genes 0.000 claims description 2
- 108090000942 Lactalbumin Proteins 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 241001529453 unidentified herpesvirus Species 0.000 claims description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- 239000012888 bovine serum Substances 0.000 claims 1
- 108010009004 proteose-peptone Proteins 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 46
- 239000006285 cell suspension Substances 0.000 description 13
- 230000035755 proliferation Effects 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 244000309466 calf Species 0.000 description 6
- 238000004114 suspension culture Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000003292 kidney cell Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000702244 Orthoreovirus Species 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- XYNOIUSAGKNPHO-UHFFFAOYSA-M sodium;hydrogen carbonate;phosphoric acid Chemical compound [Na+].OC([O-])=O.OP(O)(O)=O XYNOIUSAGKNPHO-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/135—Foot- and mouth-disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752525733 DE2525733A1 (de) | 1975-06-10 | 1975-06-10 | Verfahren zur herstellung von virusvaccinen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE43380L IE43380L (en) | 1976-12-10 |
| IE43380B1 true IE43380B1 (en) | 1981-02-11 |
Family
ID=5948685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE123476A IE43380B1 (en) | 1975-06-10 | 1976-06-09 | Process for preparing viruses |
Country Status (14)
-
1975
- 1975-01-01 AR AR26155175A patent/AR208012A1/es active
- 1975-06-10 DE DE19752525733 patent/DE2525733A1/de not_active Ceased
-
1976
- 1976-06-04 ES ES448573A patent/ES448573A1/es not_active Expired
- 1976-06-04 NL NL7606074A patent/NL7606074A/xx not_active Application Discontinuation
- 1976-06-08 IT IT2405376A patent/IT1061406B/it active
- 1976-06-08 LU LU75106A patent/LU75106A1/xx unknown
- 1976-06-08 IN IN986/CAL/1976A patent/IN141155B/en unknown
- 1976-06-09 IE IE123476A patent/IE43380B1/en unknown
- 1976-06-09 AT AT420076A patent/AT362495B/de not_active IP Right Cessation
- 1976-06-09 DK DK254876A patent/DK254876A/da unknown
- 1976-06-10 FR FR7617593A patent/FR2314252A1/fr active Granted
- 1976-06-10 BR BR7603715A patent/BR7603715A/pt unknown
- 1976-06-10 GB GB2405676A patent/GB1548258A/en not_active Expired
- 1976-06-10 BE BE167794A patent/BE842796A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2314252A1 (fr) | 1977-01-07 |
| FR2314252B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1980-01-25 |
| LU75106A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-03-09 |
| ES448573A1 (es) | 1977-07-16 |
| DE2525733A1 (de) | 1976-12-16 |
| BE842796A (fr) | 1976-12-10 |
| AT362495B (de) | 1981-05-25 |
| IN141155B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-01-22 |
| DK254876A (da) | 1976-12-11 |
| AR208012A1 (es) | 1976-11-22 |
| IT1061406B (it) | 1983-02-28 |
| GB1548258A (en) | 1979-07-11 |
| IE43380L (en) | 1976-12-10 |
| NL7606074A (nl) | 1976-12-14 |
| ATA420076A (de) | 1980-10-15 |
| BR7603715A (pt) | 1977-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10329536B2 (en) | Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture | |
| Ørskov et al. | Episome-carried surface antigen K88 of Escherichia coli I. Transmission of the determinant of the K88 antigen and influence on the transfer of chromosomal markers | |
| EP0357709B1 (en) | Preservation of viruses | |
| US3915794A (en) | Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them | |
| US20050118698A1 (en) | Multiplication of viruses in a cell culture | |
| CA2197683C (en) | Method for preparing an influenza virus, antigens obtained and applications thereof | |
| US4072565A (en) | Production of viruses in tissue culture without use of serum | |
| Taketo | Sensitivity of Escherichia coli to viral nucleic acid: v. competence of calcium-treated cells | |
| Junge et al. | Stimulation of peripheral lymphocytes by allogeneic and autochthonous mononucleosis lymphocyte cell lines | |
| Scherer et al. | Studies of viral virulence. II. Growth and adsorption curves of virulent and attenuated strains of Venezuelan encephalitis virus in cultured cells | |
| AU2007305595C1 (en) | IPV-DPT vaccine | |
| EP0027347A1 (en) | Feline infectious peritonitis virus, its preparation and vaccines containing it | |
| EP0407037A1 (en) | Process for removing bacterial endotoxin from gram-negative polysaccharides | |
| CN112410240B (zh) | 铜绿假单胞菌膜囊泡及其制备方法与应用 | |
| US3892627A (en) | Feline panleukopenia vaccine | |
| Goodman-Snitkoff et al. | The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes. | |
| IE43380B1 (en) | Process for preparing viruses | |
| US3709782A (en) | Heteroploid cell lines | |
| Chang | Properties of a Transmissible Agent Capable of Inducing Marked DNA Degradation and Thymine Catabolism in a Human Cell. | |
| YAMAMOTO et al. | Mutants of herpes simplex virus. I. Isolation and properties of mutants characterized by plaque size and cytopathogenicity | |
| Loveday et al. | The fate of bacteriophage φe transfecting DNA | |
| Levitan et al. | Preliminary biochemical characterization of the factors (s) responsible for herpesvirus-induced exogenous fusion | |
| Pasternak et al. | The inhibition of yeast carboxylase by homologous antiserum | |
| Whyte et al. | Characterization of a murine cytomegalovirus-induced immunosuppressive factor | |
| CN114306587B (zh) | 一种低血清乙型脑炎灭活疫苗的制备方法及乙型脑炎灭活疫苗 |